Low hydroxychloroquine levels and poor adherence raises SLE atherosclerotic cardiovascular disease risk, a new study has ...
Hereditary hypotrichosis showed distinct genotype–phenotype patterns, supporting phenotype-driven candidate-gene ...
Andy Plump, the research and development chief who overhauled Takeda's pipeline over more than a decade, will retire in June ...
Heart disease prevention targets remain unmet across Europe, with poor cholesterol and blood pressure control and low ...
Where do you think we are still failing to translate the evidence we already have into better diabetes care, and what could ...
The original trial focused on sustained remission, including clinical and biochemical remission, and endoscopic remission ...
Colorectal cancer circuitry involving MYC, ETS2 and FOXP1 regulated super enhancers and highlighted LGR5 activation.
AstraZeneca’s experimental COPD drug has significantly reduced flare-ups in two late-stage trials, making FDA approval in ...
An investigational MASH drug significantly reduced liver fat after 12 weeks, with no major safety concerns in a phase 2a ...
Unruptured brain aneurysms may affect one in 15 healthy adults, with prevalence more than doubling over the past two decades.
AbbVie’s atogepant has met the primary endpoint of its phase 3 trial, which tested the drug as a preventive treatment for ...
High myopia showed five 3D globe remodelling patterns, with focal deformation linked to greater structural complications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results